Schizophrenia, Market

Schizophrenia Market: RISVAN's Approval Has Sparked a Competitive Race Among Pharmaceutical Companies | DelveInsight

Veröffentlicht: 07.08.2025 um 18:08 Uhr, prnewswire.co.uk

DelveInsight Business Research, LLP United Kingdom United States of America


+14699457679

Logo: https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg 

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/schizophrenia-market-risvans-approval-has-sparked-a-competitive-race-among-pharmaceutical-companies--delveinsight-302230329.html

en | boerse | 67929715 |